{"transactions":[{"id":4635909,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:02:00.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":1099,"price":6.8372,"value":7514.0828,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":169848,"source":{"system":"sec-edgar","filing":"0001193125-26-415528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2065633/000119312526415528/ownership.xml","form_type":"4"}},{"id":4616442,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-11T22:35:23.000Z","date":"2026-09-09","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning on September 8, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four-year period."}],"balance_after":85000,"derivative":{"exercise_price":10.79,"expiration_date":"2036-09-08","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001193125-26-389510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2065633/000119312526389510/ownership.xml","form_type":"4"}},{"id":4616441,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:35:23.000Z","date":"2026-09-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":170947,"source":{"system":"sec-edgar","filing":"0001193125-26-389510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2065633/000119312526389510/ownership.xml","form_type":"4"}},{"id":4312,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:03:14.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":11.1556,"value":12271.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":140947,"source":{"system":"sec-edgar","filing":"0001193125-26-383619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2065633/000119312526383619/ownership.xml","form_type":"4"}},{"id":672078,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-31T23:06:27.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":5306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares initially subject to the option vested and became exercisable on April 8, 2026, and the balance of the shares subject to the option are vesting and becoming exercisable at a rate of 1/36th per month over the following 36 months."}],"balance_after":74265,"derivative":{"exercise_price":1.92,"expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":5306},"source":{"system":"sec-edgar","filing":"0001193125-26-377207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526377207/ownership.xml","form_type":"4"}},{"id":672077,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-31T23:06:27.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":8222,"price":12.0087,"value":98735.5314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.0087, and the range of prices were between $12.00 and $12.05, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":142047,"source":{"system":"sec-edgar","filing":"0001193125-26-377207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526377207/ownership.xml","form_type":"4"}},{"id":672076,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-31T23:06:27.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":5306,"price":1.92,"value":10187.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026."}],"balance_after":150269,"source":{"system":"sec-edgar","filing":"0001193125-26-377207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526377207/ownership.xml","form_type":"4"}},{"id":681509,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-20T01:00:36.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":false,"shares":429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares initially subject to the option vested and became exercisable on April 8, 2026, and the balance of the shares subject to the option are vesting and becoming exercisable at a rate of 1/36th per month over the following 36 months."}],"balance_after":79571,"derivative":{"exercise_price":1.92,"expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":429},"source":{"system":"sec-edgar","filing":"0001193125-26-357383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526357383/ownership.xml","form_type":"4"}},{"id":681508,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-20T01:00:36.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":429,"price":12,"value":5148.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026."}],"balance_after":144963,"source":{"system":"sec-edgar","filing":"0001193125-26-357383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526357383/ownership.xml","form_type":"4"}},{"id":681507,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-20T01:00:36.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":true,"shares":429,"price":1.92,"value":823.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026."}],"balance_after":145392,"source":{"system":"sec-edgar","filing":"0001193125-26-357383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526357383/ownership.xml","form_type":"4"}},{"id":772228,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:50:38.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":7037,"price":9.0076,"value":63386.4812,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0076, and the range of prices were between $8.7404 and $9.0104. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":144963,"source":{"system":"sec-edgar","filing":"0001193125-26-231507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526231507/ownership.xml","form_type":"4"}},{"id":897096,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T23:48:47.000Z","date":"2026-02-15","kind":"grant","planned":false,"acquired":true,"shares":102000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":152000,"source":{"system":"sec-edgar","filing":"0001193125-26-057668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526057668/ownership.xml","form_type":"4"}},{"id":1165738,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-25T21:07:02.000Z","date":"2025-04-08","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares initially subject to the option will vest and become exercisable on April 8, 2026, and the balance of the shares subject to the option shall vest and become exercisable at a rate of 1/36th per month over the following 36 months."}],"balance_after":80000,"derivative":{"exercise_price":1.92,"expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-25-011379","document":"form4-04252025_090459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588925011379/form4-04252025_090459.xml","form_type":"4"}},{"id":1165737,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":10000,"kind":"person","name":"Banerjee Subhashis","position":1,"cik":"0002065633","reported_name":"Banerjee Subhashis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-25T21:07:02.000Z","date":"2025-04-08","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-25-011379","document":"form4-04252025_090459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588925011379/form4-04252025_090459.xml","form_type":"4"}}]}